JPRN-UMIN000020562已完成未知
Clinical efficacy and safety of istradefylline in the treatment of advanced Parkinson's disease: a retrospective study
Himeji Central Hospital0 个研究点目标入组 50 人开始时间: 2016年1月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- •?Patients who received istradefylline in the period from May 2013 to May 2015
- •?Parkinson's disease patients having wearing-off phenomenon under treatment with medications containing levodopa
- •?Outpatient
排除标准
- •?Patients who have moderate or severer hepatic disorder or are receiving strong CYP3A4 inhibitors.
- •?Women who are lactating or pregnant or are suspected of being pregnant.
研究者
相似试验
已完成
不适用
ong-term efficacy and safety of istradefylline for the treatment of advanced Parkinson's diseaseJPRN-UMIN000021899Abe Neurology Clinic45
已完成
不适用
Intervention study of Istradefylline for the Treatment of Abnormal Posture in Patients with Parkinson's DiseaseParkinson's diseaseJPRN-UMIN000026492Osaka Red Cross Hospital31
已完成
不适用
Intervention Study for the effect of Istradefylline on onset of Dyskinesia in Patients with Parkinson's Disease.s diseaseParkinson's diseaseJPRN-UMIN000024536Fukuoka University214
已完成
不适用
ODYSSEI StudyParkinson's diseaseJPRN-jRCTs071180014Tsuboi Yoshio280
已完成
不适用
Intervention Study of Istradefylline for the Treatment of Gait Disorders in Patients with Parkinson's Disease.Parkinson's diseaseJPRN-UMIN000020288Juntendo University Shizuoka Hospital30